Home/ Supplements/ Echinacea/ Chimaphila Combination #1

Chimaphila Combination #1

product on market Liquid Genestra Brands Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 20% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula combines Pipsissewa and Uva-ursi, which are traditionally used for urinary tract support, alongside Echinacea and Mallow. Research evidence for these specific botanical combinations is limited. The ingredients are generally recognized as safe, though evidence for their collective efficacy remains sparse.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Chimaphila Combination #1
Open Full PDF View on NIH DSLD →
Details

Label Data

0.75 mL
Serving Size
80
Servings
Botanical
Product Type
20%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Pipsissewa (Chimaphila umbellata) aerial parts extract
0.26 mL
Uva-ursi (Arctostaphylos uva-ursi) leaf extract
0.17 mL
Market median: 400.0mg (380 products) 36 studies (A:1, B:10)
Mallow (Malva neglecta) aerial parts extract
0.11 mL
Wild Carrot (Daucus carota) aerial parts extract
0.11 mL

Other Ingredients

purified Water Ethanol
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Recommended Adult Dose: Take 15 drops three to five times daily, thirty minutes before meals, or as recommended by your healthcare practitioner.

Warnings & Precautions

Risk Information: If you are pregnant or breastfeeding; if you have heart disease, high or low blood pressure, kidney or liver disorder, diabetes or edema; if you are taking products containing diuretics; or if you are allergic or sensitive to birch, mugwort, celery and plants of the Asteraceae/Compositae/Daisy family, do not use.

Risk Information: If you are pregnant or breastfeeding; if you have heart disease, high or low blood pressure, kidney or liver disorder, diabetes or edema; if you are taking products containing diuretics; or if you are allergic or sensitive to birch, mugwort, celery and plants of the Asteraceae/Compositae/Daisy family, do not use.

Stop use and seek medical attention immediately if you experience dizziness, confusion, muscle weakness or pain, abnormal heartbeat and/or difficulty breathing. Hypersensitivity to echinacea has been known to occur; in which case, discontinue use. Avoid direct sunlight when using this product.

Quality Assurance: Safety-sealed for your protection and for product freshness. Do not use if outer seal is missing or broken.

Formulation Notes

Guaranteed to contain no added starch, soy, sodium, sugar, artificial coloring or flavoring, dairy or animal products.

Ideal for vegans.

Additional Information

Store in a cool, dry place.

V1.0 716

Seroyal

Metadata

Product Details

UPC / SKU883196 14000
DSLD Entry Date2016-02-23
Product TypeBotanical
FormLiquid
DSLD ID56444
Data Updated2026-04-11
Research

Research Evidence

38
Research Sources
52
Avg Quality
15
Meta Analysis
12
Systematic Review
6
Rct
2
Clinical Trial
1
Regulatory Source
1
Openfda Safety
A Echinacea for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
B Efficacy and safety of Echinacea purpurea in treating upper respiratory infections and complications of otitis media in children: Systematic review and meta-analysis
Meta Analysis Clinical nutrition ESPEN 2025 PubMed DOI
B Echinacea for preventing and treating the common cold
Systematic Review The Cochrane database of systematic reviews 2000 PubMed
B Echinacea Supplementation Does Not Impact Aerobic Capacity and Erythropoiesis in Athletes: A Meta-Analysis
Meta Analysis Nutrients 2024 PubMed DOI
B Echinacea for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2006 PubMed
B Therapeutic Potential of a Natural Blend of Aronia melancarpa, Lonicera caerulea, and Echinacea purpurea Extracts in Treating Upper Respiratory Tract Infections: Preliminary Clinical and In Vitro Immunomodulatory Insights
Rct International journal of molecular sciences 2024 PubMed DOI
B Herbal Medicine in Children With Respiratory Tract Infection: Systematic Review and Meta-Analysis
Meta Analysis Academic pediatrics 2018 PubMed DOI
B Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis
Meta Analysis The Lancet. Infectious diseases 2007 PubMed
B Herbal Medicine for Cough: a Systematic Review and Meta-Analysis
Meta Analysis Forschende Komplementarmedizin (2006) 2015 PubMed DOI
B Echinacea for the prevention and treatment of upper respiratory tract infections: A systematic review and meta-analysis
Meta Analysis Complementary therapies in medicine 2019 PubMed DOI
View all evidence for Echinacea →
Compare

Similar Products

View all Echinacea products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.